Antitumor Activity of New Methylpyrazolotriazine and Pyrazolobenzotriazine Derivatives Tested on MCF-7, MDA-MB-231, and BT-474 Breast Cancer Cell Lines. Voprosy onkologii, v. 72, n. 3, p. OF-2446, 3 Jul.2026.